These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15477219)

  • 21. [Junctional sequences of T cell receptor V delta 2-D delta 3 or D delta 2-D delta 3 rearrangements in acute lymphoblastic leukemia].
    Kuang S; Dong S; Gu L
    Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):532-6, 574. PubMed ID: 8556543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].
    Raciborska A; Wypych A; Rokicka-Milewska R; Siedlecki JA; Kulik J
    Przegl Lek; 2004; 61 Suppl 2():62-6. PubMed ID: 15686049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.
    Seriu T; Hansen-Hagge TE; Erz DH; Bartram CR
    Leukemia; 1995 Feb; 9(2):316-20. PubMed ID: 7869770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of minimal residual disease in leukemia using polymerase chain reaction and restriction analysis.
    Wu N; Lu S; Zhu P; Liu L; Peng Y
    Chin Med J (Engl); 1997 Jan; 110(1):73-7. PubMed ID: 9594329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
    Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
    [No Abstract]   [Full Text] [Related]  

  • 26. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
    van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
    Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pattern of clonal immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Chinese adult acute lymphoblastic leukemia patients.
    Yao L; Chen Z; Cen J; Liang J; Feng Y; He J; Qi X; Shen H
    Leuk Res; 2008 Nov; 32(11):1735-40. PubMed ID: 18456325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
    Kitchingman GR
    Leukemia; 1994 Mar; 8(3):395-401. PubMed ID: 8127144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene rearrangements in T-cell lymphoblastic lymphoma.
    Pilozzi E; Müller-Hermelink HK; Falini B; de Wolf-Peeters C; Fidler C; Gatter K; Wainscoat J
    J Pathol; 1999 Jul; 188(3):267-70. PubMed ID: 10419594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid detection of gammaT cell receptor gene rearrangements in acute lymphoblastic leukemia by electrophoresis and silver staining: implications for detection of minimal residual disease.
    Valetto A; Lanciotti M; Di Martino D; Anselmi G; Bottini F; Mori P; Candiano G
    Electrophoresis; 1998 Jun; 19(8-9):1385-7. PubMed ID: 9694286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rearrangement of T-cell receptor delta/gamma genes: application to the study of clonality in childhood B-lineage acute lymphoblastic leukaemia.
    Januszkiewicz D; Nowak J
    Acta Haematol Pol; 1994; 25(3):277-81. PubMed ID: 7992601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. V-J junctional sequences of T cell receptor gamma gene in acute lymphocytic leukemia.
    Dong S; Huang W; Tong J; Wang Z; Chen S; Chen Z; Gu L; Li X; Xie J
    Sci China B; 1995 Feb; 38(2):202-10. PubMed ID: 7755873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of single colonies reveals a diverse origin of initial clonal proliferation in B-precursor acute lymphoblastic leukemia that can precede the t(12;21) translocation.
    Weston VJ; McConville CM; Mann JR; Darbyshire PJ; Lawson S; Gordon J; Moss PA; Taylor AM; Stankovic T
    Cancer Res; 2001 Dec; 61(23):8547-53. PubMed ID: 11731441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
    Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G
    Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity of T-cell receptor gene rearrangements in South Indian patients with common acute lymphoblastic leukemia.
    Sudhakar N; Nancy NK; Rajalekshmy KR; Rajkumar T
    Iran J Immunol; 2009 Sep; 6(3):141-6. PubMed ID: 19801787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
    Schwarz AK; Stanulla M; Cario G; Flohr T; Sutton R; Möricke A; Anker P; Stroun M; Welte K; Bartram CR; Schrappe M; Schrauder A
    Ann Hematol; 2009 Sep; 88(9):897-905. PubMed ID: 19165483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia.
    Cui L; Li Z; Wu M; Li W; Gao C; Deng G
    Leuk Res; 2010 Oct; 34(10):1314-9. PubMed ID: 20034668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
    Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
    Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.